About Eric Pham
Eric Pham is a director at Ensho Therapeutics.
Experience
This experience comes from Eric Pham's profile and from SEC filings. For roles taken from filings, the years are when the filings name Eric Pham in the role, so the role may have started earlier or lasted longer.
AI
Alveus Therapeutics Inc Current
Board Observer
2026 – Present
EP
EpiBiologics Current
Board Observer
2026 – Present
Ensho Therapeutics, Inc. Current
Director
2025 – Present · Woodcliff Lake, NJ
Develops oral medicines for people with inflammatory diseases.
AV
Avego Current
Managing Director, Avego Bioscience Capital
2024 – Present
TR
TRexBio Current
Board Member
2024 – Present
BC
Blue Owl Capital
Vice President, Healthcare Opportunities
2023 – 2024
MI
MapLight Therapeutics, Inc.
Board Observer
2023 – 2024
MT
MBrace Therapeutics
Board Observer
2023 – 2024
AA
ANAVEON AG
Board Observer
2021 – 2024
AB
Aro Biotherapeutics
Board Observer
2020 – 2024
CI
Cowen Inc.
Senior Associate, Cowen Healthcare Investments
2019 – 2023
AO
Arch Oncology
Board Member
2021 – 2022
EP
Escient Pharmaceuticals
Board Observer
2020 – 2022
RS
Roivant Sciences
Senior Analyst, Investments
2018 – 2019
FS
Fannin Innovation Studio
Business Development Consultant
2017
UF
University of California, San Francisco
Cancer Biology Research Assistant
2009 – 2012
Key Colleagues at Startups
The people Eric Pham works with at each company, as listed on that company's latest Form D.
Ensho Therapeutics, Inc. · Form D, Oct 15, 2026
DF
Danielle Fry
Chief Operating Officer and Chief Legal Officer
AR
Arash Rassoulpour
Director
CS
Carlos Solorzano
Director
Gerhard Hagn
Chief Executive Officer and director
NG
Neena Bitritto-Garg
Founder and Chief Executive Officer, director
TK
Tariq Kassum
Director